Please type responses here:
First Name:
Last Name:
Email Address:
Retype Email Address:
Title:
Institution:
Phone Number:
City:
State/Province:
Alabama
Alaska
Arizona
Arkansas
California
Colorado
Connecticut
Delaware
District of Columbia
Florida
Georgia
Hawaii
Idaho
Illinois
Indiana
Iowa
Kansas
Kentucky
Louisiana
Maine
Maryland
Massachusetts
Michigan
Minnesota
Mississippi
Missouri
Montana
Nebraska
Nevada
New Hampshire
New Jersey
New Mexico
New York
North Carolina
North Dakota
Ohio
Oklahoma
Oregon
Pennsylvania
Rhode Island
South Carolina
South Dakota
Tennessee
Texas
Utah
Vermont
Virginia
Virgin Islands
Washington
West Virginia
Wisconsin
Wyoming
Alberta
British Columbia
Manitoba
New Brunswick
Newfoundland
Northwest Territories
Nova Scotia
Nunavut
Ontario
Prince Edward Island
Puerto Rico
Quebec
Saskatchewan
Yukon
Postal/Zip Code:
Country:
What topics would you like to see covered in future POC Group Webinars?
Overall, how would you rate your satisfaction with this Point of Care Web Meeting?
Extremely satisfied Very satisfied Somewhat satisfied Dissatisfied
Your feedback helps your webinar producers and sponsors improve the overall quality of their products and services.
I agree, LIFE IS BETTER CONNECTED. Please send me information on the following areas that RALS can help at the point-of-care. Choose all that apply:
Managing Operators Managing Devices Being Inspection Ready Measuring KPIs POCT program performance
What current data management system(s) are you using? Choose all that apply:
Abbott PrecisionWeb™ GEMweb® Plus Orchard® Point-of-Care Radiometer AQURE Radiometer Radiance RALS™ Connectivity System Roche cobas® IT 1000 / cobas® infinity POC SIEMENS POCcelerator™ SIEMENS RapidComm® SIEMENS UniPOC™ Telcor QML® None Other
If you chose ‘other’ in the question above, please list your current data management system(s):
Do you currently use Cepheid tests?
Yes No
Are you looking to add any new CLIA waived molecular tests this year?
Yes No
Would you like to be contacted to learn more about Cepheid's POC solutions?
Yes No
Imagine your institution is evaluating a new rapid (POC), molecular Group A strep test for pharyngitis testing in your clinics. Upon reviewing the IFU, you notice that the QC swabs must be purchased from an outside vendor and the QC swabs control panel is designated as Class I exempt, unassayed controls.
Ordering QC from an outside vendor is a problem Running QC for Strep A tests using a Class I exempt product is a problem Neither of these are a problem N/A
Are you open to learning more about how the LumiraDx Platform and microfluidic test technology might fit into your decentralized lab settings?
Yes No N/A
Would you be interested in learning how the CLIA-waived CBC can help reduce lab send outs?
Yes No
Will you be adding CLIA-waived tests to your practices within next 6 months?
Yes No
Would you like to receive ASCLS PACE credit for this session, program number 174-001-24? (If no, you do not need to complete the following questions.)
Yes No
To receive ASCLS PACE credit (PACE Program number 174-001-24, California Agency #0001) for "The 123's of ACT: What it is, Where it's Used, Which ACT's are Available, and Why the ACT Numbers are so Different" presented on January 16, 2024, you will be required to complete the following program evaluation.
If the following is true, please answer "Yes": I have attended the full instructional time for this program. I understand that completion of the program is necessary to receive the contact hours awarded for the program.
Yes No
SPEAKER RATING
To what extent was the speaker knowledgeable, organized and effective during the presentation? (Rate on scale from 1 - 5 with 1 being the lowest and 5 being the highest)
1 2 3 4 5
To what extent did the speaker clarify and focus on the stated objectives? (Rate on scale from 1 - 5 with 1 being the lowest and 5 being the highest)
1 2 3 4 5
To what extent were the speaker's teaching methods & aids appropriate & effective? (Rate on scale from 1 - 5 with 1 being the lowest and 5 being the highest)
1 2 3 4 5
OBJECTIVES RATING:
To what extent was each objective achieved?
Explain why ACTs from different systems are not the same. (Rate on scale from 1 - 5 with 1 being the lowest and 5 being the highest)
1 2 3 4 5
Develop a plan for switching from one ACT system to another. (Rate on scale from 1 - 5 with 1 being the lowest and 5 being the highest)
1 2 3 4 5
Describe why ACT and aPTT are not interchangeable. (Rate on scale from 1 - 5 with 1 being the lowest and 5 being the highest)
1 2 3 4 5
PROGRAM CONTENT RATING
To what extent did the program content relate to the program's objectives? (Rate on scale from 1 - 5 with 1 being the lowest and 5 being the highest)
1 2 3 4 5
Rate the contribution of this session to your overall knowledge of this subject. (Rate on scale from 1 - 5 with 1 being the lowest and 5 being the highest)
1 2 3 4 5
Rate your overall degree of satisfaction with this session. (Rate on scale from 1 - 5 with 1 being the lowest and 5 being the highest)
1 2 3 4 5
Comments:
Thank you for attending this PACE approved program and completing this evaluation. Questions? Call Whitehat Communications at 434 202 8365.
